Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
Turpie
Alexander G G
AG
Bauer
Kenneth A
KA
Eriksson
Bengt I
BI
Lassen
Michael R
MR
D002986:Clinical Trials as Topic / Q000592:standards; D004345:Drug Industry / Q000191:economics / Q000941:ethics; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D000077425:Fondaparinux; D006801:Humans; D019637:Orthopedic Procedures / Q000009:adverse effects; D011134:Polysaccharides / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control*; D012107:Research Design / Q000592:standards; D012109:Research Support as Topic / Q000941:ethics / Q000592:standards; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*; D020246:Venous Thrombosis / Q000209:etiology / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D011134:Polysaccharides; D000077425:Fondaparinux